VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Condition:   Postmenopausal OsteoporosisInterventions:   Drug: Teriparatide;   Drug: Risedronate;   Drug: Placebo;   Drug: Calcium;   Drug: Vitamin DSponsor:   Eli Lilly and CompanyRecruiting - verified December 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2012 Category: Research Source Type: clinical trials

VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Condition:   Postmenopausal OsteoporosisInterventions:   Drug: Teriparatide;   Drug: Risedronate;   Drug: Placebo;   Drug: Calcium;   Drug: Vitamin DSponsor:   Eli Lilly and CompanyRecruiting - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2012 Category: Research Source Type: clinical trials

VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Condition:   Postmenopausal OsteoporosisInterventions:   Drug: Teriparatide;   Drug: Risedronate;   Drug: Placebo;   Drug: Calcium;   Drug: Vitamin DSponsor:   Eli Lilly and CompanyRecruiting - verified June 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2012 Category: Research Source Type: clinical trials

VERtebral Fracture Treatment Comparisons in Osteoporotic Women
Condition:   Postmenopausal OsteoporosisInterventions:   Drug: Teriparatide;   Drug: Risedronate;   Drug: Placebo;   Drug: Calcium;   Drug: Vitamin DSponsor:   Eli Lilly and CompanyActive, not recruiting - verified July 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2012 Category: Research Source Type: clinical trials